Sometimes the best investment opportunities come wrapped in government buzzwords and unrealistic timelines.

Last Friday, the White House issued an executive order called "Unleashing American Drone Dominance." Yes, that's the actual title. And while it's long on ambition and short on specifics, buried in the bureaucratic language is something that matters for growth investors: a clear signal that the administration wants to fast-track electric vertical takeoff and landing (eVTOL) aircraft.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

Image source: Getty Images.

The executive order creates an eVTOL pilot program requiring the FAA to select at least five companies for real-world operations, with aggressive timelines that suggest political pressure to move faster than typical aviation bureaucracy allows.

While the details remain vague and the timelines optimistic, the direction is clear: America wants to lead in urban air mobility. This political tailwind arrives just as the technology reaches commercial viability, creating a rare convergence of innovation, regulation, and market demand.

Now, before you roll your eyes at another government initiative, consider this: Archer Aviation (NYSE: ACHR) and Joby Aviation (NYSE: JOBY) don't need this executive order to succeed. Both companies are working through FAA certification (though timelines for experimental aircraft are notoriously opaque), have secured major airline partnerships, and claim to be targeting commercial launches shortly.

What both companies are getting is something potentially more valuable -- political cover to move faster through the regulatory maze. Both stocks have already had massive runs over the past 12 months (Archer up 203%, Joby up 63%), but if you think flying taxis are still science fiction, you haven't been paying attention. Here's why these two pioneers look like buys even after their recent runs.

Archer Aviation: The execution story

Archer Aviation operates with remarkable efficiency for a pre-revenue company, achieving milestones that arguably justify its $5.6 billion market cap. The company's Midnight aircraft, designed to carry four passengers plus a pilot on trips up to 100 miles, recently completed piloted flights -- a critical step that positions Archer, alongside Joby, as one of America's leading eVTOL companies.

With partnerships spanning United Airlines for domestic routes and Stellantis for manufacturing expertise, Archer has assembled the pieces for rapid commercialization once certification arrives. Its Launch Edition program, securing commitments from Abu Dhabi Aviation and Ethiopian Airlines valued at up to $30 million each, provides early revenue visibility and validates international demand.

The investment case is compelling. Archer's $6 billion order backlog now exceeds its entire $5.6 billion market cap, while its hefty 11.7% short interest (as of mid-May) sets up a potential short squeeze. Though Friday's executive order lacks implementation details, it sends an unmistakable signal -- the U.S. government views eVTOL dominance as a national priority. For a company already executing ahead of most of its peers in many ways, that political validation could be the spark that sends shares soaring in the months ahead.

Joby Aviation: The deep-pocketed pioneer

Joby Aviation brings unmatched financial firepower to the eVTOL race, with $813 million in cash plus Toyota's recent $250 million investment (part of a $500 million commitment) providing runway through commercialization. The company's Q1 2025 achievements read like a pre-launch checklist: routine pilot-on-board transition flights, Virgin Atlantic partnership for U.K. market entry, fifth production aircraft powered on, and expanded Marina manufacturing facility set for June handover.

Joby benefits from Toyota's manufacturing expertise embedded directly in operations, potentially solving the hardest challenge facing aerospace start-ups -- scaling from prototypes to volume production. The company claims to be 62% complete on its side of Stage 4 FAA certification (43% on FAA's side), though investors should view these self-reported metrics skeptically given the opaque nature of experimental aircraft approval. That's not a knock against either company, but the reality of developing a new form of aviation.

With strategic partnerships including Delta Air Lines, Virgin Atlantic, and a $131 million Department of Defense contract, Joby has diversified its path to revenue across commercial, international, and military applications. And like Archer, Joby also sports a fairly high short interest, with 7.6% of outstanding shares sold short in May. As such, this eVTOL pioneer could also benefit form a short squeeze on positive news or a marketwide melt-up.

Why these two eVTOL pioneers are a buy this week

Friday's executive order accelerated the eVTOL timeline, and the market hasn't caught on. While Archer executes lean and Joby brings Toyota's backing, both companies now face compressed regulatory timelines that could pull commercial operations forward by years.

This week's setup is compelling: Heavy short interest creates squeeze potential, operational milestones keep hitting, and a fresh political catalyst has just emerged. So, for growth investors comfortable with volatility, this could be a stellar entry point.

Should you invest $1,000 in Archer Aviation right now?

Before you buy stock in Archer Aviation, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Archer Aviation wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $868,615!*

Now, it’s worth noting Stock Advisor’s total average return is 792% — a market-crushing outperformance compared to 173% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of June 2, 2025

George Budwell has positions in Archer Aviation, Joby Aviation, and Toyota Motor. The Motley Fool recommends Delta Air Lines and Stellantis. The Motley Fool has a disclosure policy.

Short-selling can deliver spectacular returns when overvalued companies collapse, but it can also create devastating losses when markets move against bearish bets. The asymmetric risk profile makes shorting particularly hazardous during periods of rapid technological change, where seemingly overpriced stocks can continue to climb as new business models emerge and mature.

The current environment presents especially treacherous conditions for short-sellers. With artificial intelligence, autonomous systems, and defense modernization driving massive government and private investment, companies operating at the intersection of these trends often defy traditional valuation metrics. What appears overvalued today can quickly transform into tomorrow's essential infrastructure provider.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

Image source: Getty Images.

Archer Aviation (NYSE: ACHR) exemplifies this dynamic perfectly. After surging 202% over the past 12 months, the electric aviation company has attracted significant short interest, with 11.7% of outstanding shares sold short as of mid-May 2025. But beneath the surface, a fundamental business transformation is underway that could make this one of the most dangerous short positions in the market.

The short thesis looks compelling on paper

Archer became a prime short target following its meteoric rise, and the bearish case appears straightforward. The company operates in the nascent electric vertical takeoff and landing (eVTOL) market with limited recurring revenue and significant regulatory hurdles ahead. Commercial air taxi operations require extensive FAA certification and, for widespread adoption, costly investments in specialized vertiport infrastructure and air traffic management systems.

Recent research from Culper Research amplified these concerns, alleging that Archer had misled investors about key development milestones and questioning the timeline for FAA certification. Culper Research accused the company of misrepresenting testing progress and aircraft readiness, claiming Archer's "continued promotion of near-term commercialization is not only premature, but reckless." Like most pre-revenue companies, Archer is valued purely on potential rather than current financial performance, making it vulnerable to any signs that development progress is falling short of expectations.

While initial operations can leverage existing helipads and airport infrastructure, the scaling challenge looms large. Widespread air taxi adoption will eventually require substantial investments in dedicated takeoff and landing facilities, charging networks, and traffic coordination systems. The capital intensity and coordination complexity create natural barriers to rapid scaling that could limit long-term revenue growth potential.

Defense contracts change everything

What short-sellers are missing is Archer's strategic pivot into defense applications through its dedicated Archer Defense unit. The company has already secured a $142 million contract with the U.S. Air Force's Agility Prime program to deliver up to six Midnight eVTOL aircraft for military evaluation. This represents roughly half of the Department of Defense's initial eVTOL investments, positioning Archer as a leading contender for larger procurement programs.

The military use case completely transforms the value proposition. Archer's Midnight aircraft offers a 20- to 50-mile range, 150 mph top speed, and acoustic signature far quieter than traditional helicopters. These characteristics make it ideal for military missions requiring stealth and agility, including quick-reaction transport, medical evacuation, resupply, and intelligence gathering operations.

More importantly, defense adoption bypasses the civilian scaling bottlenecks that concern short-sellers. Military bases already possess suitable landing areas, and the Department of Defense has established procurement pathways designed to accelerate promising technologies into operational use. Success in prototype evaluations typically leads to "programs of record" where the military commits to fleetwide adoption worth hundreds of millions to billions of dollars.

Strategic partnerships multiply the opportunity

Archer's exclusive partnership with defense technology company Anduril Industries significantly expands its addressable market and credibility within military circles. Together, they're developing hybrid-propulsion VTOL aircraft that combine electric lift with fuel-based generators for extended range, directly addressing military requirements that pure battery-powered aircraft cannot meet.

Anduril brings proven defense contracting expertise, having recently secured a $642 million Marine Corps counter-drone system deal and a $99.7 million Space Force contract. This partnership positions Archer for larger defense opportunities beyond pure aircraft sales, potentially including integrated autonomous systems and battlefield mobility solutions.

The timing couldn't be better. Recent conflicts have demonstrated the strategic value of quiet, agile aircraft that can operate in contested environments where traditional helicopters face increasing vulnerability to drone swarms and advanced air defenses. The Department of Defense is actively investing in distributed operations concepts where eVTOL aircraft play a central role, creating immediate demand for proven capabilities.

Why this matters for short-sellers

Full disclosure: I am a long-term shareholder in Archer Aviation and a firm believer in the transformational potential of eVTOL technology. This perspective undoubtedly influences my optimistic view of the company's defense pivot and long-term prospects. However, the fundamental shift from commercial-focused to defense-enabled operations represents a measurable change in Archer's risk profile that short-sellers ignore at their peril.

For short-sellers betting on commercial aviation challenges, Archer's defense transformation represents a massive blind spot. While civilian air taxi operations face legitimate scaling hurdles, military contracts provide immediate validation and revenue potential that could sustain the company through any commercial development delays.

With key partnerships with established military contractors, shorting Archer looks increasingly like a bet against the inevitable militarization of eVTOL technology. In a market where defense spending continues accelerating and autonomous systems receive priority funding, that's a dangerous position to maintain.

Should you invest $1,000 in Archer Aviation right now?

Before you buy stock in Archer Aviation, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Archer Aviation wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $651,049!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $828,224!*

Now, it’s worth noting Stock Advisor’s total average return is 979% — a market-crushing outperformance compared to 171% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of June 2, 2025

George Budwell has positions in Archer Aviation. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Passive income is essential in retirement, but building a dependable stream isn't easy. Fortunately, top-tier dividend stocks can do the heavy lifting. The key is focusing on companies with strong yields, reliable payouts, and recession-resistant business models.

In today's volatile market, where uncertainty is the only constant, dividend investing has regained its shine. High-quality stocks that return capital to shareholders offer income stability and a cushion against downside risk.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

Image source: Getty Images.

The healthcare sector stands out in this environment. Its essential nature and steady demand make it a natural haven and a fertile ground for income investors.

Two healthcare heavyweights screen as particularly attractive buys in this turbulent market. With generous yields, durable business models, and products the world can't live without, these stocks deliver a potent mix of income and long-term upside. Here's why they belong on your radar right now.

Pfizer: Pharmaceutical giant with an exceptional yield

Pfizer (NYSE: PFE) shares currently offer an eye-catching 7.8% dividend yield, putting this pharmaceutical titan among the highest-yielding stocks in the healthcare sector. This exceptional payout level reflects the market's concerns about the company's growth trajectory following the pandemic revenue boom. With shares trading at just 7.5 times forward earnings, investors are essentially being paid handsomely to wait for the company's next phase of growth.

While Pfizer's payout ratio stands at an elevated 119%, high payout ratios are commonplace in the pharmaceutical industry due to its inherently cyclical nature. Moreover, the company maintains one of the strongest balance sheets in the industry following its COVID windfall, providing ample financial flexibility to sustain its dividend while investing in future growth. Pfizer's diverse portfolio of patent-protected drugs also generates enormous cash flows that support shareholder rewards and ongoing research initiatives.

What's the core value proposition? The drugmaker faces potential policy tailwinds under the new administration, which has signaled interest in correcting the "pill penalty" that currently gives small-molecule drugs just nine years of protection from Medicare negotiation versus 13 years for biologics. Such a change could enhance the economics of Pfizer's substantial small-molecule research programs.

Additionally, Pfizer's decision to divest its off-patent division has resulted in a more focused, innovative organization better positioned for long-term growth. So, with a promising pipeline of new drugs in cancer and immunology, Pfizer offers income investors not just an exceptional current yield but also the potential for meaningful capital appreciation as new blockbuster treatments leave the lab and enter commercial production.

AbbVie: Diversified pharmaceutical giant with steady income

AbbVie (NYSE: ABBV) offers investors a 3.9% dividend yield right now, with shares trading at a forward price-to-earnings ratio of just 14. For context, the benchmark S&P 500 trades at around 19 times forward earnings estimates. The drugmaker has successfully built a diversified portfolio spanning immunology, oncology, and aesthetics that generates consistent cash flow to support shareholder returns.

Humira's loss of exclusivity has created headwinds as biosimilar competition erodes market share. However, AbbVie's newer immunology treatments, Skyrizi and Rinvoq, have demonstrated stronger clinical outcomes for psoriasis, rheumatoid arthritis, and Crohn's disease than conventional therapies. The market has responded favorably to these medications, helping to counterbalance Humira's declining sales.

Beyond immunology, AbbVie maintains strong positions in aesthetics with Botox and oncology with Imbruvica, providing revenue diversification that strengthens the company's overall financial stability. This multifaceted portfolio approach reduces dependence on any single product while creating multiple avenues for future growth.

Despite an elevated payout ratio of 259%, AbbVie's dividend remains well supported by consistent cash-flow generation from its broad product lineup. For income investors seeking healthcare exposure with reliable dividends, AbbVie offers a generous yield with the potential for moderate capital appreciation, as it fortifies its core immunology franchise and expands into other lucrative market segments.

Should you invest $1,000 in Pfizer right now?

Before you buy stock in Pfizer, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Pfizer wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $532,771!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $593,970!*

Now, it’s worth noting Stock Advisor’s total average return is 781% — a market-crushing outperformance compared to 149% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of April 21, 2025

George Budwell has positions in AbbVie and Pfizer. The Motley Fool has positions in and recommends AbbVie and Pfizer. The Motley Fool has a disclosure policy.

Market turmoil has sent tech stocks into a tailspin in early 2025. As Donald Trump's trade policies rattle global markets, even the most dominant technology companies haven't been spared. The S&P 500 has shed over 11% year to date as I write this, while the tech-heavy Nasdaq-100 has plummeted more than 16%. For opportunistic investors, however, this pullback presents a compelling chance to acquire shares of world-class businesses at bargain prices.

Rather than fleeing technology during this downturn, forward-thinking investors should consider building positions in companies poised to benefit from unstoppable trends like artificial intelligence (AI). Despite near-term headwinds, these foundational technologies continue transforming industries worldwide. Two tech giants, Nvidia (NASDAQ: NVDA) and Meta Platforms (NASDAQ: META), have been particularly hard hit and now offer exceptional value for long-term shareholders willing to weather the current volatility.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »

Image source: Getty Images.

Nvidia: The AI hardware leader at a steep discount

Nvidia shares have plummeted 34% from their 52-week high amid escalating U.S.-China tensions and new export restrictions. This dramatic sell-off has compressed Nvidia's valuation to just 21.8 times earnings estimates, far lower than the multiple it commanded at recent peaks. Last week's announcement that the company expects $5.5 billion in write-offs related to its China-specific H20 chip only accelerated the decline, yet the fundamental growth story remains intact for markets outside China.

What separates Nvidia from competitors is its formidable economic moat, built on both market-leading graphics processing unit (GPU) hardware and its proprietary Compute Unified Device Architecture (CUDA) software platform. This potent combination creates significant switching costs for AI developers, allowing Nvidia to maintain its dominance even as other tech giants such as Advanced Micro Devices work to develop alternatives. Though some analysts expect China-related revenue to rapidly approach zero, ongoing AI investments by businesses worldwide should support strong GPU sales throughout 2025.

The AI revolution remains in its earliest stages, with Nvidia positioned as the primary beneficiary of this exponential growth market. The company has expanded beyond its core GPU business into networking, software, and services, significantly enlarging its addressable market. With shares trading at their lowest valuation in years, investors have a rare opportunity to acquire this AI juggernaut at prices that substantially undervalue its long-term potential in the face of continued global AI adoption and despite current geopolitical uncertainties.

Meta Platforms: Social media giant with AI upside

Meta shares have tumbled 33% from their 52-week highs amid the broader market sell-off as I write this, creating an attractive entry point for investors in this social media powerhouse. Its stock now trades at just 19 times forward earnings estimates, down from 24 a year ago. With nearly 4 billion monthly active users across its applications, including Facebook, Instagram, WhatsApp, and Messenger, Meta maintains unrivaled scale in the social media space, benefiting from the secular shift toward digital advertising.

Moreover, the social media titan recently unveiled Llama 4, its next-generation large language model capable of understanding and generating content across various formats, including text, images, and video. This multimodal AI system puts Meta roughly at par with the latest models from Anthropic, Alphabet, and OpenAI, but Meta's true advantage lies in its unmatched distribution network.

As AI competition shifts from model development to distribution and monetization, Meta's massive user base provides a natural platform to deploy these technologies at scale, potentially driving higher engagement and advertising effectiveness.

While tariff-induced economic slowdowns could temporarily depress advertising spending, Meta might benefit from the current uncertainty surrounding TikTok's U.S. operations as advertisers seek alternative platforms. The company's dual strategy focuses on user engagement improvements through features like Stories and Reels, while enhancing its ad targeting algorithms to deliver better results for advertisers.

Though Meta faces potential regulatory challenges with a monopoly case in the U.S., and its Reality Labs division continues to consume billions in capital, these risks appear more than accounted for at current price levels. For investors seeking exposure to both digital advertising and AI, Meta offers a compelling combination of current profitability and growth potential.

Should you invest $1,000 in Nvidia right now?

Before you buy stock in Nvidia, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nvidia wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $532,771!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $593,970!*

Now, it’s worth noting Stock Advisor’s total average return is 781% — a market-crushing outperformance compared to 149% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of April 21, 2025

Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. George Budwell has positions in Nvidia. The Motley Fool has positions in and recommends Advanced Micro Devices, Alphabet, Meta Platforms, and Nvidia. The Motley Fool has a disclosure policy.

In an era of economic uncertainty and market volatility, the quest for reliable income has become increasingly important for investors. While growth stocks may capture headlines, dividend-paying companies form the backbone of many successful retirement portfolios. The appeal is straightforward: regular cash payments that arrive regardless of market conditions, providing a dependable income stream when it's needed most.

High-yield dividend stocks are particularly attractive in the current environment. With inflation gradually cooling but still a concern, and interest rates potentially trending lower in the coming years, companies that consistently distribute significant portions of their earnings to shareholders offer both immediate income and a hedge against future economic challenges.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »

Image source: Getty Images.

For income-focused investors, two energy companies stand out for their combination of substantial yields, reasonable payout sustainability, and established business models. Enterprise Products Partners (NYSE: EPD) and Duke Energy (NYSE: DUK) share a commitment to rewarding shareholders through consistent, above-average dividend payments. Here's a rundown of each company's core investing thesis and key dividend metrics.

Energy infrastructure with a generous payout

Enterprise Products Partners L.P. is a leading North American midstream energy provider, operating approximately 50,000 miles of pipelines alongside extensive storage and processing facilities. The company's business model generates steady, fee-based income from long-term contracts with minimum volume commitments, largely insulating it from commodity price swings.

With a substantial 6.9% distribution yield and over a quarter-century of consecutive annual increases to its payout, Enterprise Products Partners offers both substantial current income and a healthy amount of growth potential for income investors, driven primarily by its expanding capital investment program and strategic positioning in natural gas liquids export markets.

Equally as important, the company's fairly conservative 58.1% payout ratio and strong balance sheet (3.1x leverage ratio) imply that its distributions ought to be safe, even in this volatile market. Keeping with this theme, the midstream energy giant's recent financial results showed healthy growth, with distributable cash flow up 6% year over year to $2.2 billion.

On the value front, Enterprise Products Partners' forward price-to-earnings ratio (P/E) of approximately 10.1 represents a significant discount to the benchmark S&P 500 (SNPINDEX: ^GSPC), which trades at 19.4 times forward earnings. As a result, the company's equity offers an attractive valuation alongside its generous income stream.

What's the bottom line? Enterprise Products Partners represents a rare combination of high current yield, consistent distribution growth, and a compelling valuation. This midstream giant thus deserves serious consideration as a cornerstone holding in a dividend-focused portfolio. After all, Enterprise's critical infrastructure and increasing focus on natural gas (a transition fuel) should keep its cash flow and distributions flowing for years to come, even as the energy transition from fossil fuels to renewables evolves in the years ahead.

Powering portfolios with regulated stability

Duke Energy is one of the nation's largest utilities, delivering essential electricity and natural gas services to approximately 8.4 million electric customers and 1.7 million natural gas customers. This regulated business structure creates a solid foundation for predictable revenue and cash flow that remain relatively stable, even during economic downturns.

For income-focused investors, Duke presents a compelling opportunity with its current 3.37% dividend yield -- more than double the S&P 500's current yield of around 1.3%. While not as high as some other utilities, Duke compensates with exceptional dividend consistency, having paid dividends for 99 consecutive years and increased them annually for the past 18 years. This century-approaching dividend streak demonstrates management's unwavering commitment to shareholder returns.

Still, the company's 73% payout ratio is higher than many other blue chip dividend payers. That said, Duke's elevated payout ratio shouldn't be a major concern, given the company's steady cash flow and built-in regulatory protections.

From a valuation perspective, Duke stock trades at a forward P/E of 18.5, slightly below the S&P 500's 19.4 multiple. This relatively fair valuation is notable considering Duke's above-average growth prospects in the utility sector, supported by a 1.5% to 2% annual electricity demand growth that's expected to accelerate to 3% to 4% by 2027, thanks to rising energy demand from data centers.

The investment case in a nutshell? Duke Energy combines defensive utility characteristics with above-average growth potential in an increasingly electrified economy. While not the highest-yielding option, Duke offers a rare blend of dividend safety, growth visibility, and a reasonable valuation that makes it worthy of consideration in this challenging market.

Don’t miss this second chance at a potentially lucrative opportunity

Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this.

On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried you’ve already missed your chance to invest, now is the best time to buy before it’s too late. And the numbers speak for themselves:

• Nvidia: if you invested $1,000 when we doubled down in 2009, you’d have $244,570!*
• Apple: if you invested $1,000 when we doubled down in 2008, you’d have $35,715!*
• Netflix: if you invested $1,000 when we doubled down in 2004, you’d have $461,558!*

Right now, we’re issuing “Double Down” alerts for three incredible companies, and there may not be another chance like this anytime soon.

Continue »

*Stock Advisor returns as of April 5, 2025

George Budwell has positions in Duke Energy. The Motley Fool recommends Duke Energy and Enterprise Products Partners. The Motley Fool has a disclosure policy.